SAN DIEGO (AP) — SAN DIEGO (AP) — Mirati Therapeutics Inc. (MRTX) on Monday reported a loss of $161.9 million in its third quarter. On a per-share basis, the San Diego-based company said it had a loss of $2.49. The results topped Wall Street expectations. The average estimate of nine…Read More
Mirati Q3 Earnings Snapshot WTOP News
